$GILD Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GILEAD SCIENCES INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in GILEAD SCIENCES INC. Get notifications about new insider transactions in GILEAD SCIENCES INC for free.
Page: < prev 1 ... 41 42 43 44 45 46 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 13 2004 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | SVP, Research | Buy | M | 14.59 | 60,000 | 875,628 | 262,058 | 202.1 K to 262.1 K (+29.69 %) |
| Aug 13 2004 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Option Exercise | M | 9.56 | 4,000 | 38,250 | 70,000 | |
| Aug 13 2004 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 63.47 | 4,000 | 253,880 | 4,000 | 8 K to 4 K (-50.00 %) |
| Aug 13 2004 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Grant | A | 9.56 | 4,000 | 38,250 | 8,000 | 4 K to 8 K (+100.00 %) |
| Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Option Exercise | M | 14.81 | 7,780 | 115,241 | 11,340 | |
| Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Option Exercise | M | 14.16 | 220 | 3,114 | 0 | |
| Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 63.50 | 7,780 | 494,030 | 44,081 | 51.9 K to 44.1 K (-15.00 %) |
| Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Buy | M | 14.81 | 7,780 | 115,241 | 51,861 | 44.1 K to 51.9 K (+17.65 %) |
| Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 63.50 | 220 | 13,970 | 44,081 | 44.3 K to 44.1 K (-0.50 %) |
| Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Buy | M | 14.16 | 220 | 3,114 | 44,301 | 44.1 K to 44.3 K (+0.50 %) |
| Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Option Exercise | M | 14.81 | 7,780 | 115,241 | 11,340 | |
| Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Option Exercise | M | 14.16 | 220 | 3,114 | 0 | |
| Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 63.50 | 7,780 | 494,030 | 44,081 | 51.9 K to 44.1 K (-15.00 %) |
| Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Buy | M | 14.81 | 7,780 | 115,241 | 51,861 | 44.1 K to 51.9 K (+17.65 %) |
| Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 63.50 | 220 | 13,970 | 44,081 | 44.3 K to 44.1 K (-0.50 %) |
| Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Buy | M | 14.16 | 220 | 3,114 | 44,301 | 44.1 K to 44.3 K (+0.50 %) |
| Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Option Exercise | M | 8.19 | 15,000 | 122,813 | 213,360 | |
| Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Option Exercise | M | 8.19 | 2,000 | 16,375 | 228,360 | |
| Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Option Exercise | M | 8.19 | 13,000 | 106,438 | 230,360 | |
| Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Option Exercise | M | 8.19 | 15,000 | 122,813 | 243,360 | |
| Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Option Exercise | M | 8.19 | 5,000 | 40,938 | 258,360 | |
| Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Option Exercise | M | 8.19 | 10,000 | 81,875 | 263,360 | |
| Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 63.77 | 15,000 | 956,550 | 332,790 | 347.8 K to 332.8 K (-4.31 %) |
| Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Buy | M | 8.19 | 15,000 | 122,813 | 347,790 | 332.8 K to 347.8 K (+4.51 %) |
| Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 63.70 | 2,000 | 127,400 | 332,790 | 334.8 K to 332.8 K (-0.60 %) |
| Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Buy | M | 8.19 | 2,000 | 16,375 | 334,790 | 332.8 K to 334.8 K (+0.60 %) |
| Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 63.50 | 13,000 | 825,500 | 332,790 | 345.8 K to 332.8 K (-3.76 %) |
| Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Buy | M | 8.19 | 13,000 | 106,438 | 345,790 | 332.8 K to 345.8 K (+3.91 %) |
| Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 63.55 | 15,000 | 953,250 | 332,790 | 347.8 K to 332.8 K (-4.31 %) |
| Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Buy | M | 8.19 | 15,000 | 122,813 | 347,790 | 332.8 K to 347.8 K (+4.51 %) |
| Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 62.75 | 5,000 | 313,750 | 332,790 | 337.8 K to 332.8 K (-1.48 %) |
| Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Buy | M | 8.19 | 5,000 | 40,938 | 337,790 | 332.8 K to 337.8 K (+1.50 %) |
| Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 62.86 | 10,000 | 628,600 | 332,790 | 342.8 K to 332.8 K (-2.92 %) |
| Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Buy | M | 8.19 | 10,000 | 81,875 | 342,790 | 332.8 K to 342.8 K (+3.00 %) |
| Jul 29 2004 | GILD | GILEAD SCIENCES IN ... | CARACCIOLO ANTHONY | SVP | Option Exercise | A | 58.23 | 25,000 | 1,455,750 | 25,000 | |
| Jul 06 2004 | GILD | GILEAD SCIENCES IN ... | SHULTZ GEORGE P | Director | Option Exercise | A | 67.00 | 522 | 34,974 | 522 | |
| Jul 14 2004 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Option Exercise | M | 9.56 | 4,000 | 38,250 | 74,000 | |
| Jul 14 2004 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 65.22 | 4,000 | 260,880 | 4,000 | 8 K to 4 K (-50.00 %) |
| Jul 14 2004 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Grant | A | 9.56 | 4,000 | 38,250 | 8,000 | 4 K to 8 K (+100.00 %) |
| Jul 06 2004 | GILD | GILEAD SCIENCES IN ... | SHULTZ GEORGE P | Director | Option Exercise | A | 67.00 | 522 | 34,974 | 522 | |
| Jul 06 2004 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Option Exercise | A | 67.00 | 209 | 14,003 | 209 | |
| Jul 06 2004 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Option Exercise | A | 67.00 | 261 | 17,487 | 261 | |
| Jul 06 2004 | GILD | GILEAD SCIENCES IN ... | WILSON GAYLE E | Director | Option Exercise | A | 67.00 | 522 | 34,974 | 522 | |
| May 28 2004 | GILD | GILEAD SCIENCES IN ... | MOORE GORDON EARLE | Director | Buy | I | 61.65 | 385 | 23,735 | 385 | 0 to 385 |
| Jun 09 2004 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Option Exercise | M | 9.56 | 4,000 | 38,250 | 78,000 | |
| Jun 09 2004 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 64.84 | 4,000 | 259,360 | 4,000 | 8 K to 4 K (-50.00 %) |
| Jun 09 2004 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Grant | A | 9.56 | 4,000 | 38,250 | 8,000 | 4 K to 8 K (+100.00 %) |
| May 27 2004 | GILD | GILEAD SCIENCES IN ... | SHULTZ GEORGE P | Director | Option Exercise | A | 62.80 | 24,000 | 1,507,200 | 24,000 | |
| May 27 2004 | GILD | GILEAD SCIENCES IN ... | WILSON GAYLE E | Director | Option Exercise | A | 62.80 | 21,000 | 1,318,800 | 21,000 | |
| May 27 2004 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Option Exercise | A | 62.80 | 21,000 | 1,318,800 | 21,000 | |
| May 27 2004 | GILD | GILEAD SCIENCES IN ... | MOORE GORDON EARLE | Director | Option Exercise | A | 62.80 | 24,000 | 1,507,200 | 24,000 | |
| May 27 2004 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Option Exercise | A | 62.80 | 27,000 | 1,695,600 | 27,000 | |
| May 27 2004 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Option Exercise | A | 62.80 | 24,000 | 1,507,200 | 24,000 | |
| May 13 2004 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Option Exercise | M | 9.56 | 4,000 | 38,250 | 82,000 | |
| May 13 2004 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 55.06 | 4,000 | 220,240 | 4,000 | 8 K to 4 K (-50.00 %) |
| May 13 2004 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Grant | A | 9.56 | 4,000 | 38,250 | 8,000 | 4 K to 8 K (+100.00 %) |
| May 07 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Gift | G | 0.00 | 1,500 | 0 | 332,790 | 334.3 K to 332.8 K (-0.45 %) |
| May 07 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Gift | G | 0.00 | 1,500 | 0 | 334,290 | 335.8 K to 334.3 K (-0.45 %) |
| May 06 2004 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | SVP, Research | Option Exercise | M | 9.50 | 65,000 | 617,500 | 0 | |
| May 06 2004 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | SVP, Research | Option Exercise | M | 6.53 | 12,000 | 78,376 | 18,316 | |
| May 06 2004 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | SVP, Research | Sell | S | 58.30 | 55,000 | 3,206,500 | 202,058 | 257.1 K to 202.1 K (-21.40 %) |
| May 06 2004 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | SVP, Research | Sell | S | 58.39 | 10,000 | 583,900 | 257,058 | 267.1 K to 257.1 K (-3.74 %) |
| May 06 2004 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | SVP, Research | Buy | M | 9.50 | 65,000 | 617,500 | 267,058 | 202.1 K to 267.1 K (+32.17 %) |
| May 06 2004 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | SVP, Research | Buy | M | 6.53 | 12,000 | 78,376 | 202,058 | 190.1 K to 202.1 K (+6.31 %) |
| May 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Option Exercise | M | 14.81 | 8,000 | 118,500 | 19,120 | |
| May 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.16 | 200 | 12,032 | 44,081 | 44.3 K to 44.1 K (-0.45 %) |
| May 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.30 | 800 | 48,240 | 44,281 | 45.1 K to 44.3 K (-1.77 %) |
| May 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.36 | 500 | 30,180 | 45,081 | 45.6 K to 45.1 K (-1.10 %) |
| May 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.31 | 600 | 36,186 | 45,581 | 46.2 K to 45.6 K (-1.30 %) |
| May 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.37 | 200 | 12,074 | 46,181 | 46.4 K to 46.2 K (-0.43 %) |
| May 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.29 | 200 | 12,058 | 46,381 | 46.6 K to 46.4 K (-0.43 %) |
| May 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.28 | 100 | 6,028 | 46,581 | 46.7 K to 46.6 K (-0.21 %) |
| May 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.25 | 500 | 30,125 | 46,681 | 47.2 K to 46.7 K (-1.06 %) |
| May 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.24 | 400 | 24,096 | 47,181 | 47.6 K to 47.2 K (-0.84 %) |
| May 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.23 | 300 | 18,069 | 47,581 | 47.9 K to 47.6 K (-0.63 %) |
| May 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.22 | 300 | 18,066 | 47,881 | 48.2 K to 47.9 K (-0.62 %) |
| May 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.21 | 200 | 12,042 | 48,181 | 48.4 K to 48.2 K (-0.41 %) |
| May 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.17 | 200 | 12,034 | 48,381 | 48.6 K to 48.4 K (-0.41 %) |
| May 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.15 | 100 | 6,015 | 48,581 | 48.7 K to 48.6 K (-0.21 %) |
| May 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.12 | 100 | 6,012 | 48,681 | 48.8 K to 48.7 K (-0.20 %) |
| May 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.11 | 2,700 | 162,297 | 48,781 | 51.5 K to 48.8 K (-5.24 %) |
| May 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.38 | 100 | 6,038 | 51,481 | 51.6 K to 51.5 K (-0.19 %) |
| May 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.44 | 500 | 30,220 | 51,581 | 52.1 K to 51.6 K (-0.96 %) |
| May 05 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Buy | M | 14.81 | 8,000 | 118,500 | 52,081 | 44.1 K to 52.1 K (+18.15 %) |
| May 04 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Option Exercise | M | 5.63 | 3,500 | 19,688 | 0 | |
| May 04 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Option Exercise | M | 5.63 | 10,000 | 56,250 | 3,500 | |
| May 04 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Option Exercise | M | 5.63 | 6,500 | 36,563 | 13,500 | |
| May 04 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Option Exercise | M | 5.63 | 5,000 | 28,125 | 20,000 | |
| May 04 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Option Exercise | M | 5.63 | 5,000 | 28,125 | 25,000 | |
| May 04 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Option Exercise | M | 5.63 | 10,000 | 56,250 | 30,000 | |
| May 04 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 60.80 | 3,500 | 212,800 | 335,790 | 339.3 K to 335.8 K (-1.03 %) |
| May 04 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Buy | M | 5.63 | 3,500 | 19,688 | 339,290 | 335.8 K to 339.3 K (+1.04 %) |
| May 04 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 60.60 | 10,000 | 606,000 | 335,790 | 345.8 K to 335.8 K (-2.89 %) |
| May 04 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Buy | M | 5.63 | 10,000 | 56,250 | 345,790 | 335.8 K to 345.8 K (+2.98 %) |
| May 04 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 60.46 | 6,500 | 392,990 | 335,790 | 342.3 K to 335.8 K (-1.90 %) |
| May 04 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Buy | M | 5.63 | 6,500 | 36,563 | 342,290 | 335.8 K to 342.3 K (+1.94 %) |
| May 04 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 60.70 | 5,000 | 303,500 | 335,790 | 340.8 K to 335.8 K (-1.47 %) |
| May 04 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Buy | M | 5.63 | 5,000 | 28,125 | 340,790 | 335.8 K to 340.8 K (+1.49 %) |
| May 04 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 60.90 | 5,000 | 304,500 | 335,790 | 340.8 K to 335.8 K (-1.47 %) |
| May 04 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Buy | M | 5.63 | 5,000 | 28,125 | 335,790 | 330.8 K to 335.8 K (+1.51 %) |
| May 04 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 60.95 | 10,000 | 609,500 | 335,790 | 345.8 K to 335.8 K (-2.89 %) |
| May 04 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Buy | M | 5.63 | 10,000 | 56,250 | 345,790 | 335.8 K to 345.8 K (+2.98 %) |
| Apr 30 2004 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Option Exercise | A | 57.00 | 3,000 | 171,000 | 3,000 | |
| Apr 23 2004 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP | Option Exercise | A | 57.00 | 25,000 | 1,425,000 | 25,000 | |
| Apr 23 2004 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Option Exercise | A | 57.00 | 6,000 | 342,000 | 6,000 | |
| Apr 23 2004 | GILD | GILEAD SCIENCES IN ... | WILSON GAYLE E | Director | Option Exercise | A | 57.00 | 3,000 | 171,000 | 3,000 | |
| Apr 14 2004 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP Research and PP ... | Option Exercise | M | 6.59 | 6,000 | 39,563 | 0 | |
| Apr 14 2004 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP Research and PP ... | Buy | M | 6.59 | 6,000 | 39,563 | 6,000 | 0 to 6 K |
| Mar 25 2004 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Option Exercise | A | 53.46 | 6,000 | 320,760 | 36,000 | |
| Mar 25 2004 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Option Exercise | A | 53.46 | 30,000 | 1,603,800 | 30,000 | |
| Feb 13 2004 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | SVP, Research | Gift | G | 0.00 | 250 | 0 | 47,036 | 47.3 K to 47 K (-0.53 %) |
| Feb 13 2004 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | SVP, Research | Gift | G | 0.00 | 250 | 0 | 47,286 | 47.5 K to 47.3 K (-0.53 %) |
| Feb 13 2004 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Option Exercise | M | 9.56 | 2,000 | 19,125 | 86,000 | |
| Feb 13 2004 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Buy | M | 9.56 | 2,000 | 19,125 | 4,000 | 2 K to 4 K (+100.00 %) |
| Feb 10 2004 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Option Exercise | M | 9.56 | 8,000 | 76,500 | 88,000 | |
| Feb 10 2004 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 58.10 | 2,700 | 156,870 | 2,000 | 4.7 K to 2 K (-57.45 %) |
| Feb 10 2004 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 58.11 | 200 | 11,622 | 4,700 | 4.9 K to 4.7 K (-4.08 %) |
| Feb 10 2004 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 58.12 | 100 | 5,812 | 4,900 | 5 K to 4.9 K (-2.00 %) |
| Feb 10 2004 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 58.13 | 400 | 23,252 | 5,000 | 5.4 K to 5 K (-7.41 %) |
| Feb 10 2004 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 58.14 | 4,600 | 267,444 | 5,400 | 10 K to 5.4 K (-46.00 %) |
| Feb 10 2004 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Buy | M | 9.56 | 8,000 | 76,500 | 10,000 | 2 K to 10 K (+400.00 %) |
| Feb 09 2004 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | SVP, Research | Option Exercise | M | 5.72 | 32,516 | 185,953 | 0 | |
| Feb 09 2004 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | SVP, Research | Option Exercise | M | 9.50 | 15,000 | 142,500 | 65,000 | |
| Feb 09 2004 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | SVP, Research | Option Exercise | M | 6.53 | 6,684 | 43,655 | 0 | |
| Feb 09 2004 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | SVP, Research | Option Exercise | M | 6.53 | 5,000 | 32,657 | 30,316 | |
| Feb 09 2004 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | SVP, Research | Sell | S | 56.00 | 54,200 | 3,035,200 | 190,058 | 244.3 K to 190.1 K (-22.19 %) |
| Feb 09 2004 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | SVP, Research | Buy | M | 5.72 | 32,516 | 185,953 | 244,258 | 211.7 K to 244.3 K (+15.36 %) |
| Feb 09 2004 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | SVP, Research | Buy | M | 9.50 | 15,000 | 142,500 | 211,742 | 196.7 K to 211.7 K (+7.62 %) |
| Feb 09 2004 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | SVP, Research | Buy | M | 5.63 | 6,684 | 37,640 | 196,742 | 190.1 K to 196.7 K (+3.52 %) |
| Feb 09 2004 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | SVP, Research | Buy | M | 6.53 | 5,000 | 32,657 | 190,058 | 185.1 K to 190.1 K (+2.70 %) |
| Feb 09 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Option Exercise | M | 5.63 | 50,000 | 281,250 | 40,000 | |
| Feb 09 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Option Exercise | M | 14.59 | 10,000 | 145,938 | 24,820 | |
| Feb 09 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 56.40 | 10,000 | 564,000 | 335,790 | 345.8 K to 335.8 K (-2.89 %) |
| Feb 09 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 56.60 | 10,000 | 566,000 | 345,790 | 355.8 K to 345.8 K (-2.81 %) |
| Feb 09 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 56.55 | 10,000 | 565,500 | 355,790 | 365.8 K to 355.8 K (-2.73 %) |
| Feb 09 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 56.51 | 10,000 | 565,100 | 365,790 | 375.8 K to 365.8 K (-2.66 %) |
| Feb 09 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 56.49 | 10,000 | 564,900 | 375,790 | 385.8 K to 375.8 K (-2.59 %) |
| Feb 09 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Buy | M | 5.63 | 50,000 | 281,250 | 385,790 | 335.8 K to 385.8 K (+14.89 %) |
| Feb 09 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Buy | M | 6.53 | 10,000 | 65,313 | 335,790 | 325.8 K to 335.8 K (+3.07 %) |
| Feb 04 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Option Exercise | M | 14.81 | 7,000 | 103,688 | 27,120 | |
| Feb 04 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 56.95 | 700 | 39,865 | 44,081 | 44.8 K to 44.1 K (-1.56 %) |
| Feb 04 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 56.90 | 500 | 28,450 | 44,781 | 45.3 K to 44.8 K (-1.10 %) |
| Feb 04 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 56.89 | 5,800 | 329,962 | 45,281 | 51.1 K to 45.3 K (-11.35 %) |
| Feb 04 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Buy | M | 14.81 | 7,000 | 103,688 | 51,081 | 44.1 K to 51.1 K (+15.88 %) |
| Feb 04 2004 | GILD | GILEAD SCIENCES IN ... | PERRY MARK L | EVP Operations | Option Exercise | M | 14.81 | 40,000 | 592,500 | 53,252 | |
| Feb 04 2004 | GILD | GILEAD SCIENCES IN ... | PERRY MARK L | EVP Operations | Option Exercise | M | 14.59 | 9,716 | 141,793 | 19,432 | |
| Feb 04 2004 | GILD | GILEAD SCIENCES IN ... | PERRY MARK L | EVP Operations | Option Exercise | M | 14.59 | 2,284 | 33,332 | 4,568 | |
| Feb 04 2004 | GILD | GILEAD SCIENCES IN ... | PERRY MARK L | EVP Operations | Gift | G | 0.00 | 300 | 0 | 5,600 | 5.3 K to 5.6 K (+5.66 %) |
| Feb 04 2004 | GILD | GILEAD SCIENCES IN ... | PERRY MARK L | EVP Operations | Gift | G | 0.00 | 300 | 0 | 196,040 | 196.3 K to 196 K (-0.15 %) |
| Feb 04 2004 | GILD | GILEAD SCIENCES IN ... | PERRY MARK L | EVP Operations | Sell | S | 56.79 | 4,716 | 267,822 | 196,340 | 201.1 K to 196.3 K (-2.35 %) |